Cargando…
Detection of Circulating Tumor DNA Methylation in Diagnosis of Colorectal Cancer
Emerging evidence has demonstrated the potential of the circulating tumor DNA (ctDNA) methylation in the application of cancer diagnosis. METHODS: Three genes including Septin9, Syndecan-2 (SDC2), and branched-chain amino acid transaminase 1 (BCAT1), which have been well demonstrated to have aberran...
Autores principales: | Xu, Fei, Yu, Shanshan, Han, Junyi, Zong, Ming, Tan, Qi, Zeng, Xin, Fan, Lieying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367071/ https://www.ncbi.nlm.nih.gov/pubmed/34382948 http://dx.doi.org/10.14309/ctg.0000000000000386 |
Ejemplares similares
-
Hypoxia-induced miR-191-C/EBPβ signaling regulates cell proliferation and apoptosis of fibroblast-like synoviocytes from patients with rheumatoid arthritis
por: Yu, Shanshan, et al.
Publicado: (2019) -
Circulating tumor DNA methylation marker MYO1-G for diagnosis and monitoring of colorectal cancer
por: Lin, Wu-Hao, et al.
Publicado: (2021) -
Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer
por: Mitchell, Susan M., et al.
Publicado: (2016) -
Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction
por: Nassar, Farah J., et al.
Publicado: (2021) -
Predicting disease-free survival in colorectal cancer by circulating tumor DNA methylation markers
por: Yang, Xin, et al.
Publicado: (2022)